Is LXEO or MAZE more undervalued in 2026?

CirclFi compares Lexeo Therapeutics, Inc. (LXEO) and Maze Therapeutics, Inc. (MAZE) using 13 institutional-grade valuation models. LXEO has a Quality of Company score of 4.5/10 while MAZE scores 5.4/10.

Which is a better buy — LXEO or MAZE?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do LXEO and MAZE valuations compare?

LXEO at $5.08 and MAZE at $26.40 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

LXEO vs MAZE Valuation Comparison 2026 — Intrinsic Value Analysis

LXEO

Biotechnology

Lexeo Therapeutics, Inc.

Quality

4.5

out of 10

Value Trap

SAFE

Price

$5.08

Last close

Models

7/13

Active

MAZE

Biotechnology

Maze Therapeutics, Inc.

Quality

5.4

out of 10

Value Trap

—

Price

$26.40

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	LXEO Fair Value	LXEO Upside	MAZE Fair Value	MAZE Upside
Bayesian DCF	Intrinsic	$1.83	-64.1%	$3.40	-87.1%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$2.81	-44.7%	$7.76	-71.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for LXEO vs MAZE — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

LXEO vs MAZE — Which Stock Is More Undervalued?

MAZE scores higher with a 5.4/10 quality rating vs LXEO's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Lexeo Therapeutics, Inc. (LXEO) and Maze Therapeutics, Inc. (MAZE) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

LXEO currently trades at $5.08 with a QOC of 4.5/10, while MAZE trades at $26.40 with a QOC of 5.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).